142 related articles for article (PubMed ID: 2965547)
1. [Combination chemotherapy using low-dose epirubicin and vindesine in patients with metastatic breast cancer].
Takatsuka Y; Nakayama H; Kawahara T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):667-71. PubMed ID: 2965547
[TBL] [Abstract][Full Text] [Related]
2. [Intra-arterial infusion chemotherapy for advanced or recurrent breast cancers].
Okazaki M; Okazaki A; Masuoka H; Toda K; Yamada T; Okazaki Y; Asaishi K; Hirata K; Narimatsu E
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():94-101. PubMed ID: 7747999
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
4. [Effects of neoadjuvant intra-arterial infusion chemotherapy in patients with stage III breast carcinoma].
Higuchi K; Onda M; Furukawa K; Minobe K; Tanaka N; Arima Y; Hasegawa H
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1799-802. PubMed ID: 9382536
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
[TBL] [Abstract][Full Text] [Related]
6. [Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Watanabe O; Shimizu T; Imamura H; Kinoshita J; Okabe T; Ogawa K; Haga S
Gan To Kagaku Ryoho; 2004 May; 31(5):717-21. PubMed ID: 15170979
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials].
Jouve M; Palangie T; Belli L; Dorval T; Garcia-Giralt E; Beuzeboc P; Scholl S; Mosseri V; Livartowski A; Vedrenne J
Bull Cancer; 1989; 76(6):643-52. PubMed ID: 2673438
[TBL] [Abstract][Full Text] [Related]
8. [A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
Kusama M; Kaise H; Nakayama S; Oota D; Shimizu H; Aoki T; Koyanagi Y
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2243-7. PubMed ID: 11142170
[TBL] [Abstract][Full Text] [Related]
9. [Results of combination therapy of UFT-E with low-dose CDDP for patients with advanced recurrent breast cancer].
Ito T; Yamada M; Tanemura H; Oshita H; Asano M; Saji S
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1575-80. PubMed ID: 9725051
[TBL] [Abstract][Full Text] [Related]
10. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
11. [Adriamycin, cyclophosphamide, ftorafur and tamoxifen (ACFT) in patients with advanced breast cancer].
Imajo K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Ozeki H; Nagamine D; Shinagawa K; Fukutani H
Gan To Kagaku Ryoho; 1988 Jan; 15(1):121-6. PubMed ID: 3122665
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer.
Pannuti F; Martoni A; Piana E; Tomasi L; Grieco A; Farris A; Saccani F; Baroni M
Chemioterapia; 1984 Aug; 3(4):211-5. PubMed ID: 6241846
[TBL] [Abstract][Full Text] [Related]
13. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
Wander HE; Nagel GA
Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
[TBL] [Abstract][Full Text] [Related]
14. [A case of inflammatory breast cancer treated with medroxyprogesterone acetate (MPA) in combination with intra-arterial infusion chemotherapy].
Yamada T; Okazaki M; Okazaki A; Sato H; Watanabe Y; Toda K; Okazaki Y; Asaishi K; Hirata K; Narimatsu E
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1923-5. PubMed ID: 1387777
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
[TBL] [Abstract][Full Text] [Related]
16. [Phase II study of combination chemotherapy with epirubicin, cyclophosphamide and ftorafur in metastatic breast cancer].
Shinagawa K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Mizunuma N
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3277-81. PubMed ID: 3143311
[TBL] [Abstract][Full Text] [Related]
17. [Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer].
Wada N; Kobayashi H; Oka S; Ando J; Tamura H
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1935-42. PubMed ID: 12465393
[TBL] [Abstract][Full Text] [Related]
18. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer].
Kiman K; Suzuki S; Satomi T; Sakonji M; Nihei M; Tanaka T; Kimijima I; Abe R
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2445-52. PubMed ID: 7944490
[TBL] [Abstract][Full Text] [Related]
20. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
